Long-term management of chronic DIC associated with inoperable aortic aneurysm with low molecular weight heparin

Gautam Majumdar1

  • 1Haematology Department, Doncaster Royal Infirmary, Thorne Road, Doncaster, DN2 5LT, UK. gautam.majumdar@dbh.nhs.uk

Insights

Chronic disseminated intravascular coagulation (DIC), a rare aortic aneurysm complication, can be managed with heparin for inoperable cases. This report details successful long-term dalteparin management for a patient with inoperable aortic aneurysm and chronic DIC.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Surgery

Background:

  • Chronic disseminated intravascular coagulation (DIC) is a rare complication associated with aortic aneurysms.
  • Surgical correction is the primary treatment for aortic aneurysms.
  • Heparin therapy is an alternative for patients with inoperable aneurysms or persistent DIC post-surgery.

Observation:

  • A patient presented with multiple, inoperable aortic aneurysms.
  • The patient also had chronic disseminated intravascular coagulation (DIC).

Findings:

  • The patient was successfully managed with dalteparin, a low-molecular-weight heparin, over an extended period.
  • This case highlights the efficacy of long-term anticoagulation in managing chronic DIC secondary to aortic aneurysms in challenging clinical scenarios.

Implications:

  • Long-term anticoagulation with agents like dalteparin can be a viable therapeutic option for chronic DIC in patients with inoperable aortic aneurysms.
  • This approach may help control coagulopathy and improve outcomes in select patient populations.
  • Further research into anticoagulation strategies for chronic DIC in vascular disease is warranted.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...